Guided Therapeutics (GTHP) Net Margin (2010 - 2025)
Guided Therapeutics' Net Margin came in at -210.51% for Q4 2025, up 69789.49 percentage points from -70000.00% a year earlier and up 1097.82 percentage points from the prior quarter.
Powered by 
Analysis
Guided Therapeutics (GTHP) Net Margin (2010 - 2025) Analysis & Trends
For FY2025, Guided Therapeutics' Net Margin was -436.25%, up 36578.04 percentage points from FY2024.
- Net Margin carries a five-year change of -43.11 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -37014.29% in FY2024 (-33178.57 pp), -3835.71% in FY2023 (+34410.44 pp), -38246.15% in FY2022 (-35244.92 pp) and -3001.23% in FY2021 (-2608.10 pp).
- The Q4 2025 figure represents the highest quarterly Net Margin since Q4 2020.
- The fastest year-over-year change in Net Margin over five years came in Q4 2025 (a gain of 69789.49 percentage points), and the weakest in Q4 2024 (a drop of 68534.38 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 14.47% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 7.37% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 13.89% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 28.29% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 15.07% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 19.37% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 16.67% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 13.89% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 7.57% |
| 10 | Guided Therapeutics | 19.31 Mn | 18.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -210.51% |
| Sep 30, 2025 | -1,308.33% |
| Jun 30, 2025 | -731.62% |
| Dec 31, 2024 | -70,000.00% |
| Mar 31, 2024 | -7,350.00% |
| Dec 31, 2023 | -1,465.63% |
| Jun 30, 2023 | -3,645.45% |
| Mar 31, 2023 | -4,404.55% |
| Sep 30, 2022 | -35,133.33% |
| Jun 30, 2022 | -20,140.00% |
| Mar 31, 2022 | -21,100.00% |
| Dec 31, 2021 | -848.33% |
| Sep 30, 2021 | -268.42% |
| Jun 30, 2021 | -57,950.00% |
| Dec 31, 2020 | 8,476.00% |
| Sep 30, 2020 | 1,985.71% |
| Dec 31, 2019 | 6,768.75% |
| Sep 30, 2019 | -12,600.00% |
| Jun 30, 2019 | -265,400.00% |
| Mar 31, 2019 | -1,244.44% |
API Access
Guided Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=GTHP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "GTHP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=GTHP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();